NEW YORK -Shares of biotechnology company Amgen Inc. rose Wednesday following a move by the U.S. Senate to pass a resolution requesting the Centers for Medicare and Medicaid Services reconsider a reimbursement decision on anemia drugs.The stock rose $1.92, or 3.9 percent, to $53.32 in morning trading. Shares have traded between $48.30 and $77 over the last 52 weeks.
